FILE - Similac Alimentum Hypoallergenic Infant Formula, imported from Puerto Rico, is for sale at a Stew Leonard's grocery store in Yonkers, New York, Friday, June 10, 2022. The FDA acknowledged Tuesday, Sept. 20, that its response to the national shortage of infant formula was slowed by delays in processing a whistleblower complaint and test samples from the nations largest manufacturing plant. A 10-page report from the agency offers the first formal account of the factors that led to the ongoing infant formula shortage. (AP Photo/Ted Shaffrey, File)
WASHINGTON – The Food and Drug Administration acknowledged Tuesday that its response to the U.S. infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.
A 10-page report from the agency offers its first formal account of the factors that led to the ongoing shortage, which has forced the U.S. to airlift millions of pounds of powdered formula from overseas.
The review zeroed in on several key problems at the agency, including outdated data-sharing systems, inadequate staffing and training among its food inspectors, and poor visibility into formula supply chains and manufacturing procedures.
“For things that are critical to the public health, if you don’t have some understanding of how all the pieces fit together, then when you get into a crisis or a shortage you have a real problem,” FDA Commissioner Robert Califf told The Associated Press...
Professional rivalry and office politics were the driving forces behind the "false" sexual harassment and conversion allegations levelled against Tata Consulting Services (TCS) employee Raza Rafiq...